Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07029139 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy

Name: A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy — clinical trial record (NCT07029139)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 2

SponsorShanghai JMT-Bio Inc.

Started2025-06-30

View on ClinicalTrials.gov ↗

Shanghai JMT-Bio Inc.

31 trials monitored

See all monitored trials

This study is a multicenter, randomized, controlled, open-label, Phase Ⅱ clinical study to evaluate the efficacy, safety, Pharmacokinetics characteristics, Pharmacodynamics effects, and immunogenicity of JMT601 in participants with primary membranous nephropathy. The study has two parts. Part one is dose escalation part, and Part two is dose expansion part.

Trial Details

NCT Number	NCT07029139
Lead Sponsor	Shanghai JMT-Bio Inc.
Conditions	Primary Membranous Nephropathy
Enrollment	156 participants
Start Date	2025-06-30
Primary Completion	2027-04-01 (estimated)
Study Completion	2029-03-01 (estimated)
Updated on ClinicalTrials.gov	2025-06-19